Rivaroxaban tablets bulk supplier for pharma manufacturers

Rivaroxaban Tablets 10 mg, 15 mg, 20 mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 10 mg, 15 mg, 20 mg

Reference Brands: Xarelto(US & EU), Rivabloc (India), Rivax (LATAM)

Rivaroxaban inhibits factor Xa, reducing thrombin generation and clot formation. It effectively prevents strokes, deep vein thrombosis, and pulmonary embolism. Benefits include oral administration, predictable effects, no routine blood monitoring needed, and rapid onset, making it a convenient and effective anticoagulant for both prophylaxis and treatment of thromboembolic disorders.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Rivaroxaban Tablets? List it or send an offer →

Product Description:

Rivaroxaban is a widely used oral anticoagulant regulated by the FDA in the US and the EMA in the EU. It requires a robust dossier demonstrating safety, efficacy, and manufacturing quality for approval. In the US, it is approved as Xarelto, with a focus on stroke prevention, DVT, and PE treatment. In the EU, similar approvals are granted through centralized procedures, ensuring compliance with regional standards. Ensuring regulatory compliance is critical for successful registration and commercialization of rivaroxaban products globally.

Rivaroxaban Tablets — third party manufacturing & bulk supply

Rivaroxaban Tablets 10 mg, 15 mg, 20 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Rivaroxaban Tablets is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Rivaroxaban Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Rivaroxaban Tablets →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Rivaroxaban is used to prevent and treat blood clots in conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. It is also used for the prevention of venous thromboembolism (VTE) in patients undergoing hip or knee replacement surgery.

Rivaroxaban is a direct factor Xa inhibitor that selectively blocks factor Xa in the coagulation cascade, reducing thrombin generation and preventing clot formation.

The primary trade name is Xarelto, along with various generic brands available worldwide.

Rivaroxaban is manufactured by Bayer and is also produced by multiple pharmaceutical companies globally as a generic medicine.

The generic name is Rivaroxaban.

Brand names include Xarelto and other regional generics.

Rivaroxaban is manufactured in the USA, Europe, India, and other regions by multiple pharmaceutical companies under approved regulatory standards.

Xarelto (rivaroxaban) was discovered by Bayer, which sells it in most countries. In the United States it is marketed by Janssen, part of Johnson & Johnson. Xarelto is a trademark of Bayer; PharmaTradz is not affiliated with or endorsed by Bayer or Johnson & Johnson.

Yes, in many markets. Generic rivaroxaban is widely sold in India, the UK and most of Europe, and in the US generic versions of some strengths are available. Patent status still differs by market and strength, so we confirm what can be supplied to your destination before quoting.